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Genetic association study of a single nucleotide 
polymorphism of kallikrein-related peptidase 2 with 
male infertility
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Objective: To investigate a kallikrein-related peptidase 2 (KLK2) single nucleotide polymorphism (SNP) in relation to male infertility because of 
its role in semen processing. We investigated the genetic association of the KLK2+255G>A genotype with male infertility.
Methods: We genotyped the SNP site located in intron 1 (+255G>A, rs2664155) of KLK2 from 218 men with male infertility (cases) and 220 
fertile males (controls). Pyrosequencing analysis was performed for the genotyping. 
Results: The SNP of the KLK2 gene had a statistically significant association with male infertility (p<0.05). The odds ratio for the minor allele 
(+255A) in the pooled sample was 0.47 (95% confidence intervals, 0.26-0.85) for rs2664155.
Conclusion: The relationship of KLK2 SNP to male infertility is statistically significant, especially within the non-azoospermia group. Further 
study is needed to understand the mechanisms associated with male infertility. 
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Introduction
Several risk factors for male infertility have recently been identified, 
such as chromosomal abnormalities, Y-chromosome microdeletions, 
translocation, cystic fibrosis transmembrane conductance regulator 
mutations, and other genetic factors [1]. A significant percentage of 
couples (30-40%) fail to achieve pregnancy despite several IUI at-
tempts, even in cases without a clear male infertility factor, which 
suggests the existence of an occult cause of male infertility that has 
lately been linked to molecular factors and not to sperm count, mo-
tility, or morphology [2]. 
Semen liquefaction is achieved through a stepwise proteolytic cleav-
age of the gel proteins semenogelin I and II (SgI and SgII) into soluble 
proteins, followed by their peptidic fragmentation. Liquefaction of 
human semen involves proteolytic degradation of the seminal coag-
ulum and release of motile spermatozoa. Several members of human 
kallikrein-related peptidases (KLKs) have been implicated in semen 
liquefaction [3]. 
Kallikreins are serine proteases that belong to the human tissue kal-
likrein family, which included 15 members (KLK1-KLK15) [4]. The KLK2 
gene is located on chromosome 19q13.41. It consists of five exons 
and is 5,217 bp in length [5]. Three glandular kallikreins are encoded 
by the human kallikrein gene family: tissue kallikrein (KLK1), human 
kallikrein-related peptidase 2 (KLK2), and prostate-specific antigen 
(PSA or KLK3) [6]. Kallikrein is assumed to improve sperm motility 
due to enzyme activation [7]. Kallikrein is a glycoprotein involved in 
the enzymatic activation of kininogens that has been shown to have 
a positive effect on sperm motility in vitro and on the stimulation of 
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sperm metabolism [4]. Since the amount of KLK2 in seminal plasma 
is lower than PSA (1-5%), it is a key regulatory factor for KLK protease 
cascade [8]. Therefore, we searched for any association of KLK2 single 
nucleotide polymorphism (SNP) with male infertility. 
Methods
1. Patients and control 
Two hundred twenty fertile men who had fathered at least one 
child and who lacked any history of requiring assisted reproductive 
technology were included as the control group. This control group 
was consecutively enrolled from the Division of Genome Resources, 
National Genome Research Institute, National Institutes of Health, 
and from Korea [1,9]. From January 2002 to August 2006, 709 non-
obstructive infertile men were identified following physical examina-
tions and hormone assays. Infertile men without any chromosome 
abnormality were selected for this association study. These non-ob-
structive infertile men (those with spermatogenesis problems) were 
further sub-divided following semen analysis performed strictly ad-
hering to the World Health Organization guidelines [10]. The diagno-
ses of non-azoospermia were made on the basis of two semen analy-
ses performed according to World Health Organization recommend-
ed procedures. Non-azoospermia (n=218) included men having at 
least one abnormality in sperm concentration (<20×10
6), motility 
(<50%), or morphology (<14%). The experiments were performed 
at the CHA General Hospital, Seoul, Korea. Informed consent was re-
quired to participate in this study [9]. 
2. Pyrosequencing for genotyping
The PCR primers were designed using PRIMER3 (http://frodo.wi.mit. 
edu/cgi-bin/primer3/primer3_www.cgi) and Pyrosequencing Primer 
SNP Design ver. 1.01 software. The pyrosequencing reactions were 
automatically performed with a PSQ 96 system (Pyrosequencing AB) 
according to the manufacturer’s instructions. Briefly, the biotinylated 
PCR product (50 µL) was purified using streptavidin-Sepharose beads. 
The single-strand PCR product acted as a template in the pyrosequen-
cing reaction [1]. All reactions were constructed as recommended by 
the manufacturer’s instructions (Pyrosequencing, Westborough, MA, 
USA). The pyrosequencing reaction was performed automatically us-
ing a PSQ 96 MA system (Pyrosequencing AB, Uppsala, Sweden) and 
also with a SNA Reagent Kit (Biotage AB, Uppsala, Sweden). The PCR 
conditions were 95°C for 15 minutes, 95°C for 30 seconds, 54°C for 30 
seconds, and 72°C for 30 seconds for 40 cycles. The biotinylated PCR 
product was purified by using streptavidin-Sepharose beads. The py-
rosequencing reaction was performed automatically using a PSQ 
96MA system along with a SNP Reagent Kit. All reactions were per-
formed as recommended by the manufacturer’s instruction (Pyrose-
quencing).
3. Statistical analysis
Multiple logistic regression models were used to calculate odds ra-
tios, 95% confidence intervals (CIs), and corresponding p-values. 
These analyses were performed using SAS statistical software (SAS 
Enterprise Guide, Cary, NC, USA) [11]. Student’s t-tests (Analysis of 
variation, ANOVA) were used to compare the expression levels of KLK2 
genotypes (GG vs. AA). Statistical significance was assumed at a p-
value less than 0.05.
Results
1. KLK cascade for semen liquefaction
KLK2 is a highly prostate-specific serine protease (hK2), which is 
mainly excreted into the seminal fluid, but part of which is also se-
creted into circulation from prostatic tumors and benign prostatic 
hyperplasia tissue [12-14]. Specifically, hK2 has an 80% identity in 
primary structure with PSA (hK3), and both proteins have high tran-
scripts, particularly in the prostate [15]. hK2 is responsible for the ac-
tivation of PSA (hK3) by cleaving its pro-form to the enzymatically 
active mature form in the prostate [16] (Figure 1). In the prostate, the 
propeptides are removed from proPSA and prohK2, leaving the ma-
ture, catalytic forms. KLK2 might be one of the proteases responsible 
for these processing events. PSA and hK2 are released at high con-
centrations into prostatic fluid, then into seminal fluid. hK2 and PSA 
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Figure 1. Kallikrein-related peptidase (KLK) cascade for semen lique-
faction. Active types of prostate-specific antigen (PSA; KLK3) and 
KLK2 are shown as gray incomplete round forms, and inactive types 
as black ovals (proKLK2 and proPSA). KLK2 is responsible for the acti-
vation of PSA and itself by cleaving pro-forms to the enzymatically 
active mature forms inside the prostate. PCI indicates protein C in-
hibitor, and SEMG1-2 are semenogelin I and II.  doi: 10.5653/cerm.2011.38.1.6
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forms in prostatic fluid are active, nicked, and complex forms with 
protein C inhibitor (PCI), which is a protease inhibitor [15]. 
2. Statistically significant association of the KLK2 gene with 
male infertility
Since hK2 is mostly present in semen, the genetic association study 
was performed the KLK2 gene with male infertility. We selected a 
SNP site of the KLK2 gene located in intron 1 (IVS1+255, rs2664155) 
because of its previously reported association with prostate cancer 
[5]. The association study was performed with 218 infertile men (cas-
es) with 220 fertile male controls. Genetic analysis showed that IVS1+ 
255 SNP was significantly associated only with the non-azoospermia 
group (n=218, p<0.05). For IVS1+255 SNP, the allele frequency of 
the variant type (+255A) was 16.8% in fertile males (n=220) and 8.7% 
in non-azoospermia males (n=218, p<0.01) (Table 1). The SNP of 
the KLK2 gene had a statistically significant association with male in-
fertility (p<0.05). The OR for the minor allele (+255A) in the pooled 
sample was 0.47 (95% CI, 0.26-0.85) for rs 2664155. 
Discussion
In our study, we examined how the polymorphism of KLK2 may af-
fect male infertility because of its role in semen processing. Genotype 
association analysis showed that the KLK2 intron 1 (+255G>A) SNP 
is associated with male infertility, especially with non-azoospermia. 
Human KLKs are a family of proteases, the majority of which are 
found in seminal plasma. The physical properties of ejaculate (coagu-
lation, liquefaction, volume, and viscosity) have clinical implications 
in male infertility with concurrent delayed liquefaction, which has 
also been associated with sperm parameters [17]. Kallikrein is assum-
ed to be related to the improvement of sperm motility due to enzyme 
activation, in addition to semen liquefaction [18]. Kallikrein is a glyco-
protein involved in the enzymatic activation of kininogens that has a 
positive effect on sperm motility in vitro and stimulates sperm meta-
bolism. From a prostate cancer study conducted with the KLK2 gene, 
we know that there could be simple linkage disequilibrium with an-
other unknown SNP involved in regulatory functioning [5]. Defining 
the functional significance of KLK2 SNP may be necessary for the elu-
cidation of its biological effect with male infertility. Further study of 
its polymorphic effect by investigating the KLK2 intron 1 (+255G>A) 
SNP and other linked SNPs in the KLK2 gene is needed.
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